Advate
octocog alfa
Hemophilia A
Date of authorisation:
Revision: 32
Last updated:
MedicineHumanAuthorised
Teriflunomide Accord
teriflunomide
Multiple Sclerosis, Relapsing-Remitting
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanAuthorised
Teriflunomide Mylan
teriflunomide
Multiple Sclerosis, Relapsing-Remitting
Date of authorisation:
Revision: 1
Last updated:
MedicineHumanAuthorised
Aubagio
teriflunomide
Multiple Sclerosis
Date of authorisation:
Revision: 26
Last updated:
MedicineHumanAuthorised
Kovaltry
octocog alfa
Hemophilia A
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
EMEA-001064-PIP01-10-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0060/2018
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder and solvent for solution for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Kogenate Bayer
octocog alfa
Hemophilia A
Date of authorisation:
Revision: 30
Last updated:
MedicineHumanLapsed
Helixate NexGen
octocog alfa
Hemophilia A
Date of authorisation:
Revision: 31
Last updated:
MedicineHumanWithdrawn
Iblias
octocog alfa
Hemophilia A
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanWithdrawn